obstructive-hcm-medication.com domain details, Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info
Description: See Important Safety Information and Full Prescribing Information, including Boxed WARNING. CAMZYOS™ (mavacamten) is a prescription heart medicine used for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) treatment.
Domain rank: 100000000
Indexed URLs from obstructive-hcm-medication.com website (10)
The links in column here only counts links from external domains.
found date
links in
url title
url
2022-07-08
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info
2022-07-08
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info
2022-07-23
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info
2022-07-08
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment - Rx CAMZYOS® (mavacamten) - Safety Info
2022-09-28
2024-07-22
2022-09-28
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info
2022-07-08
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info
2024-07-22
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment - Rx CAMZYOS® (mavacamten) - Safety Info
2022-07-08
Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment Option | Rx CAMZYOS™ (mavacamten) | Safety Info